Accordingly, this study confirmed that the administration of KOK and KOK + P. lobata mixture for 12 weeks did not increase the risk of ER activity, potentially decreasing the risk of female diseases such as breast cancer and uterine myoma. This evidence concerns the gene ESR1 and breast cancer.